Medications and diabetes risk :: mechanisms and approach to risk reduction /
More than 23 million Americans currently have diabetes and approximately 54 million have pre-diabetes. People with diabetes often also require medications for several co-morbid conditions (including hypertension, dyslipidemia, depression, heart disease, pain syndromes). Yet, a vast literature abound...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford :
Oxford University Press,
[2011]
|
| Schriftenreihe: | Oxford American pocket notes.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | More than 23 million Americans currently have diabetes and approximately 54 million have pre-diabetes. People with diabetes often also require medications for several co-morbid conditions (including hypertension, dyslipidemia, depression, heart disease, pain syndromes). Yet, a vast literature abounds on the potential adverse effects of numerous medications on glucose metabolism. Thus, genuine clinical concern exists that certain medications used for treatment of co-morbid conditions and other indications (such as hormone replacement, contraception, infections) might worsen glycemic control in. |
| Beschreibung: | 1 online resource (95 pages) : illustrations |
| Bibliographie: | Includes bibliographical references (pages 70-95). |
| ISBN: | 9780199749553 0199749558 1306168627 9781306168625 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn864900275 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 131210s2011 enka ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OCLCO |d YDXCP |d IDEBK |d EBLCP |d OCLCQ |d OCLCO |d AGLDB |d OCLCQ |d OCLCF |d OCLCQ |d VTS |d STF |d M8D |d OCLCQ |d UKSSU |d OCLCQ |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 864746257 |a 1154835395 | ||
| 020 | |a 9780199749553 |q (electronic bk.) | ||
| 020 | |a 0199749558 |q (electronic bk.) | ||
| 020 | |a 1306168627 | ||
| 020 | |a 9781306168625 | ||
| 020 | |z 9780199734313 | ||
| 020 | |z 0199734313 | ||
| 035 | |a (OCoLC)864900275 |z (OCoLC)864746257 |z (OCoLC)1154835395 | ||
| 037 | |a 548113 |b MIL | ||
| 050 | 4 | |a RC660 |b .D26 2011eb | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 7 | |a 616.4/62061 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Dagogo-Jack, Sam, |d 1954- |0 http://id.loc.gov/authorities/names/n91098771 | |
| 245 | 1 | 0 | |a Medications and diabetes risk : |b mechanisms and approach to risk reduction / |c Samuel Dagogo-Jack, MD, FRCP, Mullins Professor in Translational Research, professor of Medicine & Chief, Division of Endocrinology, Diabetes & Metabolism, University of Tennessee Health Science Center, Memphis, TN. |
| 264 | 1 | |a Oxford : |b Oxford University Press, |c [2011] | |
| 300 | |a 1 online resource (95 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Oxford American pocket notes | |
| 504 | |a Includes bibliographical references (pages 70-95). | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a More than 23 million Americans currently have diabetes and approximately 54 million have pre-diabetes. People with diabetes often also require medications for several co-morbid conditions (including hypertension, dyslipidemia, depression, heart disease, pain syndromes). Yet, a vast literature abounds on the potential adverse effects of numerous medications on glucose metabolism. Thus, genuine clinical concern exists that certain medications used for treatment of co-morbid conditions and other indications (such as hormone replacement, contraception, infections) might worsen glycemic control in. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Diabetes |x Etiology |x Drugs. | |
| 650 | 0 | |a Diabetes |x Treatment |x Complications. | |
| 650 | 0 | |a Drugs |x Side effects. |0 http://id.loc.gov/authorities/subjects/sh85039746 | |
| 650 | 0 | |a Drug interactions. |0 http://id.loc.gov/authorities/subjects/sh85039701 | |
| 650 | 0 | |a Hypoglycemic agents. |0 http://id.loc.gov/authorities/subjects/sh85063785 | |
| 650 | 0 | |a Diabetes |x Oral therapy. |0 http://id.loc.gov/authorities/subjects/sh85037462 | |
| 650 | 2 | |a Drug-Related Side Effects and Adverse Reactions |0 https://id.nlm.nih.gov/mesh/D064420 | |
| 650 | 2 | |a Drug Combinations |0 https://id.nlm.nih.gov/mesh/D004338 | |
| 650 | 2 | |a Drug Interactions |0 https://id.nlm.nih.gov/mesh/D004347 | |
| 650 | 2 | |a Hypoglycemic Agents |0 https://id.nlm.nih.gov/mesh/D007004 | |
| 650 | 6 | |a Médicaments |x Effets secondaires. | |
| 650 | 6 | |a Interactions médicamenteuses. | |
| 650 | 6 | |a Hypoglycémiants. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Diabetes |x Oral therapy |2 fast | |
| 650 | 7 | |a Drug interactions |2 fast | |
| 650 | 7 | |a Drugs |x Side effects |2 fast | |
| 650 | 7 | |a Hypoglycemic agents |2 fast | |
| 758 | |i has work: |a Medications and diabetes risk (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGVkfrcTcbK6pVrpjYrtqP |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Dagogo-Jack, Sam, 1954- |t Medications and diabetes risk |z 9780199734313 |w (DLC) 2011286627 |w (OCoLC)710886733 |
| 830 | 0 | |a Oxford American pocket notes. |0 http://id.loc.gov/authorities/names/no2010038979 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=669964 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH26130411 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL1573125 | ||
| 938 | |a EBSCOhost |b EBSC |n 669964 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis26869338 | ||
| 938 | |a YBP Library Services |b YANK |n 11406310 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn864900275 |
|---|---|
| _version_ | 1816882252969148416 |
| adam_text | |
| any_adam_object | |
| author | Dagogo-Jack, Sam, 1954- |
| author_GND | http://id.loc.gov/authorities/names/n91098771 |
| author_facet | Dagogo-Jack, Sam, 1954- |
| author_role | |
| author_sort | Dagogo-Jack, Sam, 1954- |
| author_variant | s d j sdj |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC660 |
| callnumber-raw | RC660 .D26 2011eb |
| callnumber-search | RC660 .D26 2011eb |
| callnumber-sort | RC 3660 D26 42011EB |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)864900275 |
| dewey-full | 616.4/62061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.4/62061 |
| dewey-search | 616.4/62061 |
| dewey-sort | 3616.4 562061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04608cam a2200841 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn864900275</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">131210s2011 enka ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDXCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">STF</subfield><subfield code="d">M8D</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKSSU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">864746257</subfield><subfield code="a">1154835395</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780199749553</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199749558</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1306168627</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781306168625</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780199734313</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0199734313</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)864900275</subfield><subfield code="z">(OCoLC)864746257</subfield><subfield code="z">(OCoLC)1154835395</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">548113</subfield><subfield code="b">MIL</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC660</subfield><subfield code="b">.D26 2011eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">112000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.4/62061</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dagogo-Jack, Sam,</subfield><subfield code="d">1954-</subfield><subfield code="0">http://id.loc.gov/authorities/names/n91098771</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medications and diabetes risk :</subfield><subfield code="b">mechanisms and approach to risk reduction /</subfield><subfield code="c">Samuel Dagogo-Jack, MD, FRCP, Mullins Professor in Translational Research, professor of Medicine & Chief, Division of Endocrinology, Diabetes & Metabolism, University of Tennessee Health Science Center, Memphis, TN.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford :</subfield><subfield code="b">Oxford University Press,</subfield><subfield code="c">[2011]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (95 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Oxford American pocket notes</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 70-95).</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">More than 23 million Americans currently have diabetes and approximately 54 million have pre-diabetes. People with diabetes often also require medications for several co-morbid conditions (including hypertension, dyslipidemia, depression, heart disease, pain syndromes). Yet, a vast literature abounds on the potential adverse effects of numerous medications on glucose metabolism. Thus, genuine clinical concern exists that certain medications used for treatment of co-morbid conditions and other indications (such as hormone replacement, contraception, infections) might worsen glycemic control in.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diabetes</subfield><subfield code="x">Etiology</subfield><subfield code="x">Drugs.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diabetes</subfield><subfield code="x">Treatment</subfield><subfield code="x">Complications.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Side effects.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85039746</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug interactions.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85039701</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Hypoglycemic agents.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85063785</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diabetes</subfield><subfield code="x">Oral therapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85037462</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug-Related Side Effects and Adverse Reactions</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D064420</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Combinations</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004338</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Interactions</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004347</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hypoglycemic Agents</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D007004</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Effets secondaires.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Interactions médicamenteuses.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Hypoglycémiants.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Clinical Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Diseases.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Evidence-Based Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Internal Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diabetes</subfield><subfield code="x">Oral therapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug interactions</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="x">Side effects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hypoglycemic agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Medications and diabetes risk (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGVkfrcTcbK6pVrpjYrtqP</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Dagogo-Jack, Sam, 1954-</subfield><subfield code="t">Medications and diabetes risk</subfield><subfield code="z">9780199734313</subfield><subfield code="w">(DLC) 2011286627</subfield><subfield code="w">(OCoLC)710886733</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Oxford American pocket notes.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2010038979</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=669964</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH26130411</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL1573125</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">669964</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">cis26869338</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">11406310</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn864900275 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:25:40Z |
| institution | BVB |
| isbn | 9780199749553 0199749558 1306168627 9781306168625 |
| language | English |
| oclc_num | 864900275 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (95 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Oxford University Press, |
| record_format | marc |
| series | Oxford American pocket notes. |
| series2 | Oxford American pocket notes |
| spelling | Dagogo-Jack, Sam, 1954- http://id.loc.gov/authorities/names/n91098771 Medications and diabetes risk : mechanisms and approach to risk reduction / Samuel Dagogo-Jack, MD, FRCP, Mullins Professor in Translational Research, professor of Medicine & Chief, Division of Endocrinology, Diabetes & Metabolism, University of Tennessee Health Science Center, Memphis, TN. Oxford : Oxford University Press, [2011] 1 online resource (95 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Oxford American pocket notes Includes bibliographical references (pages 70-95). Print version record. More than 23 million Americans currently have diabetes and approximately 54 million have pre-diabetes. People with diabetes often also require medications for several co-morbid conditions (including hypertension, dyslipidemia, depression, heart disease, pain syndromes). Yet, a vast literature abounds on the potential adverse effects of numerous medications on glucose metabolism. Thus, genuine clinical concern exists that certain medications used for treatment of co-morbid conditions and other indications (such as hormone replacement, contraception, infections) might worsen glycemic control in. English. Diabetes Etiology Drugs. Diabetes Treatment Complications. Drugs Side effects. http://id.loc.gov/authorities/subjects/sh85039746 Drug interactions. http://id.loc.gov/authorities/subjects/sh85039701 Hypoglycemic agents. http://id.loc.gov/authorities/subjects/sh85063785 Diabetes Oral therapy. http://id.loc.gov/authorities/subjects/sh85037462 Drug-Related Side Effects and Adverse Reactions https://id.nlm.nih.gov/mesh/D064420 Drug Combinations https://id.nlm.nih.gov/mesh/D004338 Drug Interactions https://id.nlm.nih.gov/mesh/D004347 Hypoglycemic Agents https://id.nlm.nih.gov/mesh/D007004 Médicaments Effets secondaires. Interactions médicamenteuses. Hypoglycémiants. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetes Oral therapy fast Drug interactions fast Drugs Side effects fast Hypoglycemic agents fast has work: Medications and diabetes risk (Text) https://id.oclc.org/worldcat/entity/E39PCGVkfrcTcbK6pVrpjYrtqP https://id.oclc.org/worldcat/ontology/hasWork Print version: Dagogo-Jack, Sam, 1954- Medications and diabetes risk 9780199734313 (DLC) 2011286627 (OCoLC)710886733 Oxford American pocket notes. http://id.loc.gov/authorities/names/no2010038979 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=669964 Volltext |
| spellingShingle | Dagogo-Jack, Sam, 1954- Medications and diabetes risk : mechanisms and approach to risk reduction / Oxford American pocket notes. Diabetes Etiology Drugs. Diabetes Treatment Complications. Drugs Side effects. http://id.loc.gov/authorities/subjects/sh85039746 Drug interactions. http://id.loc.gov/authorities/subjects/sh85039701 Hypoglycemic agents. http://id.loc.gov/authorities/subjects/sh85063785 Diabetes Oral therapy. http://id.loc.gov/authorities/subjects/sh85037462 Drug-Related Side Effects and Adverse Reactions https://id.nlm.nih.gov/mesh/D064420 Drug Combinations https://id.nlm.nih.gov/mesh/D004338 Drug Interactions https://id.nlm.nih.gov/mesh/D004347 Hypoglycemic Agents https://id.nlm.nih.gov/mesh/D007004 Médicaments Effets secondaires. Interactions médicamenteuses. Hypoglycémiants. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetes Oral therapy fast Drug interactions fast Drugs Side effects fast Hypoglycemic agents fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85039746 http://id.loc.gov/authorities/subjects/sh85039701 http://id.loc.gov/authorities/subjects/sh85063785 http://id.loc.gov/authorities/subjects/sh85037462 https://id.nlm.nih.gov/mesh/D064420 https://id.nlm.nih.gov/mesh/D004338 https://id.nlm.nih.gov/mesh/D004347 https://id.nlm.nih.gov/mesh/D007004 |
| title | Medications and diabetes risk : mechanisms and approach to risk reduction / |
| title_auth | Medications and diabetes risk : mechanisms and approach to risk reduction / |
| title_exact_search | Medications and diabetes risk : mechanisms and approach to risk reduction / |
| title_full | Medications and diabetes risk : mechanisms and approach to risk reduction / Samuel Dagogo-Jack, MD, FRCP, Mullins Professor in Translational Research, professor of Medicine & Chief, Division of Endocrinology, Diabetes & Metabolism, University of Tennessee Health Science Center, Memphis, TN. |
| title_fullStr | Medications and diabetes risk : mechanisms and approach to risk reduction / Samuel Dagogo-Jack, MD, FRCP, Mullins Professor in Translational Research, professor of Medicine & Chief, Division of Endocrinology, Diabetes & Metabolism, University of Tennessee Health Science Center, Memphis, TN. |
| title_full_unstemmed | Medications and diabetes risk : mechanisms and approach to risk reduction / Samuel Dagogo-Jack, MD, FRCP, Mullins Professor in Translational Research, professor of Medicine & Chief, Division of Endocrinology, Diabetes & Metabolism, University of Tennessee Health Science Center, Memphis, TN. |
| title_short | Medications and diabetes risk : |
| title_sort | medications and diabetes risk mechanisms and approach to risk reduction |
| title_sub | mechanisms and approach to risk reduction / |
| topic | Diabetes Etiology Drugs. Diabetes Treatment Complications. Drugs Side effects. http://id.loc.gov/authorities/subjects/sh85039746 Drug interactions. http://id.loc.gov/authorities/subjects/sh85039701 Hypoglycemic agents. http://id.loc.gov/authorities/subjects/sh85063785 Diabetes Oral therapy. http://id.loc.gov/authorities/subjects/sh85037462 Drug-Related Side Effects and Adverse Reactions https://id.nlm.nih.gov/mesh/D064420 Drug Combinations https://id.nlm.nih.gov/mesh/D004338 Drug Interactions https://id.nlm.nih.gov/mesh/D004347 Hypoglycemic Agents https://id.nlm.nih.gov/mesh/D007004 Médicaments Effets secondaires. Interactions médicamenteuses. Hypoglycémiants. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetes Oral therapy fast Drug interactions fast Drugs Side effects fast Hypoglycemic agents fast |
| topic_facet | Diabetes Etiology Drugs. Diabetes Treatment Complications. Drugs Side effects. Drug interactions. Hypoglycemic agents. Diabetes Oral therapy. Drug-Related Side Effects and Adverse Reactions Drug Combinations Drug Interactions Hypoglycemic Agents Médicaments Effets secondaires. Interactions médicamenteuses. Hypoglycémiants. HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Diabetes Oral therapy Drug interactions Drugs Side effects Hypoglycemic agents |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=669964 |
| work_keys_str_mv | AT dagogojacksam medicationsanddiabetesriskmechanismsandapproachtoriskreduction |